Cas 957793-37-2,2-chloro-5-[5-(4-isobutyl-phenyl)-1,3,4-oxadiazol-2-yl]pyridine

957793-37-2

Post Buying Request

Basic information

Product Name: 2-chloro-5-[5-(4-isobutyl-phenyl)-1,3,4-oxadiazol-2-yl]pyridine
Synonyms: 2-chloro-5-[5-(4-isobutyl-phenyl)-1,3,4-oxadiazol-2-yl]pyridine
CAS NO:957793-37-2
Molecular Formula:
Molecular Weight: 313.787
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-chloro-5-[5-(4-isobutyl-phenyl)-1,3,4-oxadiazol-2-yl]pyridine(CAS DataBase Reference)
NIST Chemistry Reference: 2-chloro-5-[5-(4-isobutyl-phenyl)-1,3,4-oxadiazol-2-yl]pyridine(957793-37-2)
EPA Substance Registry System: 2-chloro-5-[5-(4-isobutyl-phenyl)-1,3,4-oxadiazol-2-yl]pyridine(957793-37-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 957793-37-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

957793-37-2 Suppliers

Recommended suppliers

957793-37-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 957793-37-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,7,9 and 3 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 957793-37:
(8*9)+(7*5)+(6*7)+(5*7)+(4*9)+(3*3)+(2*3)+(1*7)=242
242 % 10 = 2
So 957793-37-2 is a valid CAS Registry Number.

957793-37-2Upstream product

51707-37-0 4-isobutyl-benzohydrazide

957793-37-2Downstream Products

957793-37-2Relevant academic research and scientific papers

CYCLOALKYLAMINO ACID DERIVATIVES

-

Page/Page column 34, (2008/06/13)

The invention relates to compounds of formula I and to pharmaceutically acceptable salts, prodrugs, solvates or hydrates thereof; wherein B, D, E, R1, R2, R3, R4, R5, R8, m, n, p, q, r, s, t and u are as defined herein. This invention also relates to a method of using such compounds in the treatment of hyperproliferative diseases and autoimmune diseases in mammals, especially humans, and to pharmaceutical compositions containing such compounds.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 957793-37-2